Drug Type Small molecule drug |
Synonyms DRL-17564 |
Target |
Action agonists, modulators |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists), PPARγ modulators(Peroxisome proliferator-activated receptor γ modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Discovery | India | - |





